Response and prognosis after neoadjuvant chemotherapy in 1,051 patients with infiltrating lobular breast carcinoma
✍ Scribed by Loibl, Sibylle (author);Volz, Cristina (author);Mau, Christine (author);Blohmer, Jens Uwe (author);Costa, Serban D. (author);Eidtmann, Holger (author);Fasching, Peter A. (author);Gerber, Bernd (author);Hanusch, Claus (author);Jackisch, Christian (author);Kümmel, Sherko (author);Huober, Jens (author);Denkert, Carsten (author);Hilfrich, Jörn (author);Konecny, Gottfried E. (author);Fett, Werner (author);Stickeler, Elmar (author);Harbeck, Nadia (author);Mehta, Keyur M. (author);Nekljudova, Valentina (author);Von Minckwitz, Gunter (author);Untch, Michael (author)
- Book ID
- 121552311
- Publisher
- Springer New York LLC
- Year
- 2014
- Tongue
- English
- Weight
- 465 KB
- Volume
- 144
- Category
- Article
- ISSN
- 0167-6806
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## BACKGROUND. Neoadjuvant chemotherapy (NC) reportedly downstages axilla in approximately one-third of patients with locally advanced breast carcinoma (LABC). Postchemotherapy axillary lymph node status is an important prognostic factor. In the current study, the authors evaluated the reliability